Orthopediatrics Free Cash Flow (FCF) History (KIDS)
Orthopediatrics reported −$16.0M in free cash flow for fiscal 2025, an increase of $25.4M from the previous fiscal year, with a free cash flow margin of −6.75%.
View full Orthopediatrics company overviewOrthopediatrics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$16.0M | $25.4M | — | −6.75% |
| 2024 | 2024-12-31 | −$41.3M | $2.6M | — | −20.18% |
| 2023 | 2023-12-31 | −$43.9M | −$12.1M | — | −29.53% |
| 2022 | 2022-12-31 | −$31.8M | −$10.6M | — | −26.00% |
| 2021 | 2021-12-31 | −$21.2M | $7.9M | — | −21.59% |
| 2020 | 2020-12-31 | −$29.0M | $551,000 | — | −40.85% |
| 2019 | 2019-12-31 | −$29.6M | −$8.7M | — | −40.78% |
| 2018 | 2018-12-31 | −$20.8M | −$8.4M | — | −36.20% |
| 2017 | 2017-12-31 | −$12.4M | −$7.0M | — | −27.23% |
| 2016 | 2016-12-31 | −$5.5M | −$2.4M | — | −14.66% |
| 2015 | 2015-12-31 | −$3.1M | — | — | −10.01% |
Orthopediatrics quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$3.1M | $10.8M | — | −4.42% |
| Q1 2026 | 2026-03-31 | −$5.0M | $3.3M | — | −8.50% |
| Q4 2025 | 2025-12-31 | $9.7M | $14.0M | — | +15.83% |
| Q3 2025 | 2025-09-30 | −$3.4M | $8.2M | — | −5.58% |
| Q2 2025 | 2025-06-30 | −$13.9M | −$1.1M | — | −22.77% |
| Q1 2025 | 2025-03-31 | −$8.4M | $4.8M | — | −15.99% |
| Q4 2024 | 2024-12-31 | −$4.2M | $7.1M | — | −8.07% |
| Q3 2024 | 2024-09-30 | −$11.7M | −$512,000 | — | −21.37% |
| Q2 2024 | 2024-06-30 | −$12.8M | −$2.8M | — | −24.20% |
| Q1 2024 | 2024-03-31 | −$13.2M | −$1.7M | — | −29.43% |
| Q4 2023 | 2023-12-31 | −$11.4M | −$7.5M | — | −30.25% |
| Q3 2023 | 2023-09-30 | −$11.1M | −$4.0M | — | −27.89% |
| Q2 2023 | 2023-06-30 | −$10.0M | $3.4M | — | −25.27% |
| Q1 2023 | 2023-03-31 | −$11.4M | −$3.0M | — | −36.09% |
| Q4 2022 | 2022-12-31 | −$3.9M | −$994,000 | — | −12.47% |
| Q3 2022 | 2022-09-30 | −$7.1M | −$4.2M | — | −20.45% |
| Q2 2022 | 2022-06-30 | −$13.4M | −$2.7M | — | −40.81% |
| Q1 2022 | 2022-03-31 | −$8.4M | −$3.7M | — | −35.85% |
| Q4 2021 | 2021-12-31 | −$2.9M | $1.3M | — | −11.57% |
| Q3 2021 | 2021-09-30 | −$2.9M | $2.0M | — | −11.69% |
| Q2 2021 | 2021-06-30 | −$10.7M | −$1.7M | — | −40.09% |
| Q1 2021 | 2021-03-31 | −$4.7M | $6.2M | — | −21.73% |
| Q4 2020 | 2020-12-31 | −$4.2M | $4.0M | — | −22.26% |
| Q3 2020 | 2020-09-30 | −$5.0M | −$2.5M | — | −22.31% |
| Q2 2020 | 2020-06-30 | −$9.0M | $1.5M | — | −65.90% |
| Q1 2020 | 2020-03-31 | −$10.9M | −$2.5M | — | −66.70% |
| Q4 2019 | 2019-12-31 | −$8.2M | −$5.4M | — | −43.30% |
| Q3 2019 | 2019-09-30 | −$2.5M | −$125,000 | — | −11.82% |
| Q2 2019 | 2019-06-30 | −$10.5M | −$2.5M | — | −57.66% |
| Q1 2019 | 2019-03-31 | −$8.4M | −$630,000 | — | −57.55% |
| Q4 2018 | 2018-12-31 | −$2.8M | $1.8M | — | −19.12% |
| Q3 2018 | 2018-09-30 | −$2.3M | −$1.6M | — | −14.70% |
| Q2 2018 | 2018-06-30 | −$8.0M | −$2.3M | — | −53.30% |
| Q1 2018 | 2018-03-31 | −$7.8M | −$6.5M | — | −64.53% |
| Q4 2017 | 2017-12-31 | −$4.6M | — | — | −39.22% |
| Q3 2017 | 2017-09-30 | −$765,000 | — | — | −6.18% |
| Q2 2017 | 2017-06-30 | −$5.7M | — | — | −48.64% |
| Q1 2017 | 2017-03-31 | −$1.3M | — | — | −13.70% |
Orthopediatrics free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$29.0M to −$16.0M, a net increase of $13.1M. Orthopediatrics's latest reported quarter, Q2 2026, generated −$3.1M in free cash flow, an increase of $10.8M year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Orthopediatrics filings at SEC.gov ↗